Edmond de Rothschild Holding’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-99,360
Closed -$9.87M 623
2019
Q3
$9.87M Sell
99,360
-206,440
-68% -$19.6M 0.39% 69
2019
Q2
$28.3M Sell
305,800
-292,629
-49% -$27.8M 1.06% 29
2019
Q1
$56.5M Sell
598,429
-131,741
-18% -$11.5M 1.95% 12
2018
Q4
$46.8M Buy
730,170
+59,645
+9% +$4.4M 1.64% 18
2018
Q3
$60M Buy
670,525
+2,415
+0.4% +$213K 1.71% 13
2018
Q2
$53.1M Buy
668,110
+176,596
+36% +$14.7M 1.52% 15
2018
Q1
$43.8M Buy
491,514
+251,900
+105% +$24.2M 1.28% 19
2017
Q4
$25M Sell
239,614
-24,267
-9% -$2.74M 0.72% 41
2017
Q3
$38.5M Sell
263,881
-35,682
-12% -$4.86M 1.1% 21
2017
Q2
$38.9M Sell
299,563
-569
-0.2% -$69.7K 1.1% 21
2017
Q1
$37.3M Buy
300,132
+8,794
+3% +$1.05M 0.99% 28
2016
Q4
$33.7M Buy
291,338
+29,166
+11% +$3.25M 0.93% 27
2016
Q3
$27.4M Buy
262,172
+8,000
+3% +$866K 0.83% 36
2016
Q2
$25.1M Buy
254,172
+10,195
+4% +$1.05M 0.8% 36
2016
Q1
$24.4M Buy
243,977
+13,515
+6% +$1.39M 0.78% 35
2015
Q4
$27.6M Buy
230,462
+8,950
+4% +$1.04M 0.73% 42
2015
Q3
$24M Buy
221,512
+4,077
+2% +$506K 0.59% 55
2015
Q2
$25.2M Buy
+217,435
New +$24.9M 0.54% 59

Other funds holding CELG

Edmond de Rothschild Holding's CELG Position: Q4 2019 in Review

Edmond de Rothschild Holding sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 99,360 shares — an estimated $9.87M sold.

Edmond de Rothschild Holding first reported a position in CELG in Q2 2015 and held it in 18 quarters. The position peaked at $60M in Q3 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Edmond de Rothschild Holding reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Edmond de Rothschild Holding sold 99,360 Celgene Corp shares in Q4 2019, an estimated $9.87M.
  • Edmond de Rothschild Holding first reported a position in Celgene Corp in Q2 2015 and held it in 18 quarters.
  • Edmond de Rothschild Holding's Celgene Corp position peaked at $60M in Q3 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Edmond de Rothschild Holding's 13F filing for Q4 2019, filed 14 Feb 2020.